Abstract
Background Social distancing measures designed to contain the COVID-19 pandemic can explicitly and implicitly restrict physical activity, a particular concern for high-risk patient groups. Using a within-subjects design with objective measurement (via validated accelerometers), we assessed rheumatoid arthritis patients’ physical activity and sedentary behavior levels prior to and during the social distancing measures implemented in Sao Paulo, Brazil.
Methods Post-menopausal women diagnosed with rheumatoid arthritis were assessed before (from March 2018 to March 2020) and during (from 24th May to 7th July 2020) social distancing measures to contain COVID-19 pandemic, using a within-subjects, repeated-measure design. Physical activity and sedentary behavior were assessed using postural-based accelerometry (ActivPAL micro™).
Findings Mean age was 60.9 years (95%CI: 58.0, 63.7) and BMI was 29.5 Kg/m2 (95%CI: 27.2, 31.9). Disease activity ranged from remission to moderate activity. Most of the patients were using disease-modifying anti-rheumatic drugs and prednisone. Hypertension and dyslipidemia were the most frequent comorbidities During social distancing, there were reductions in total stepping time (15.7% [−0.3 h/day, 95%CI: −0.4, −0.1; p = 0.004]), in light-intensity activity (13.0% [−0.2 h/day, 95%CI: −0.4, −0.04; p = 0.016]) and in moderate-to-vigorous physical activity (38.8% [−4.5 min/day, 95%CI: −8.1, −0.9; p = 0.015]), but no changes in total standing time or total sedentary time. However, time spent in prolonged bouts of sitting ≥ 30 min increased by 34% 1.0 h/day, 95%CI: 0.3, 1.7; p=0.006) and sitting bouts ≥60 min increased by 85% (1.0 h/day, 95%CI: 0.5, 1.6) Sit-stand transitions were reduced by 10% (−5.1/day, 95%CI: −10.3, 0.0; p = 0.051)
Conclusion Imposed social distancing measures to contain the COVID-19 outbreak were associated with decreased physical activity and increased prolonged sitting among rheumatoid arthritis patients. Since this has the potential to increase the burden of cardiovascular disease in such high-risk patients, attention to maintaining physical activity is an urgent consideration during the pandemic.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
AJP, SMS and BG were supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, 2015/26937-4; 2019/15231-4; 2017/13552-2). DR and KM were supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Finance Code 001.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This trial was approved by the local ethical committee (Commission for Analysis of Research Projects).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as Clinicaltrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data will be available upon reasonable request.
